NAD+ / MOTS-c / 5-Amino-1MQ Blend
For Research Use Only
Injectable
A research blend combining a redox coenzyme with a mitochondrial-derived peptide sequence and an NNMT-pathway inhibitor, studied for intersecting roles in cellular energy metabolism. Each component is characterized separately in metabolic research literature. Laboratory research areas include: mitochondrial signaling, NAD+ pool dynamics, and multi-pathway metabolic assays.
Size: 100/10/10mg
$250.00
In stockCheckout opens once payment is connected.
Certificates of analysis
- Batch LL-QC84513729 (published 2026-06-24)
Research guides
- NAD+ and Cellular Redox Metabolism: What the Published Research ReportsA research-framed overview of published in vitro, animal, and human studies on the NAD+/NADH redox couple, its subcellular compartmentation, the genetically encoded tools used to measure and manipulate it, and the metabolic states reported when that ratio shifts.
- Measuring NAD+ by HPLC and Mass Spectrometry: What the Analytical Literature ReportsA research-framing overview of published HPLC and LC-MS/MS methods used to quantify NAD+ and related pyridine nucleotides, covering HILIC and ion-pairing reversed-phase separations, isotope-dilution internal standards, reported detection limits and validation parameters, and the biological matrices — microbial, cell-culture, animal, and human — in which each method was tested.
- NAD+ and Mitochondrial Metabolism: What the Research Literature ReportsA research-framed overview of published work on NAD+ in mitochondrial metabolism, covering the identification of the mitochondrial NAD+ transporter SLC25A51 in cell systems, compartment-specific NAD+/NADH measurement and manipulation tools, sirtuin-linked findings in rodent and invertebrate models, and observational metabolic data from human tissues. Each finding is labelled by the model in which it was studied.
This product is not for human or animal consumption. Misuse of this product is illegal.